DANIELLE MILLS: Open Payments
NPI 1366916041 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 14 payments from 8 companies in 2025. Trend: 2023 $61 · 2024 $285 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| Amgen Inc. | 2 | $36 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $33 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| AtriCure, Inc. | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
| Zimmer Biomet Holdings, Inc. | 1 | $15 |
Products named: LEQVIO, REPATHA, LifeVest, FUROSCIX, NEXLETOL, SYNERGY ABLATION SYSTEM, ENTRESTO, WATCHMAN Access System.
Industry payments across MO — which companies pay providers there.
